"Competitive Analysis of Executive Summary Alpha and Beta Emitters Based Radiopharmaceuticals Market Size and Share CAGR Value The global alpha and beta emitters based radiopharmaceuticals market size was valued at USD 801.45 million in 2024 and is expected to reach USD 1,769.20 million by 2032, at a CAGR of 10.4% during the forecast period A competition...

"Executive Summary Immuno-Oncology (IO) Market Size and Share Analysis Report Data Bridge Market Research analyses that the immuno-oncology (IO) market, which is USD 28.10 billion in 2022, is expected to reach USD 156.05 billion by 2030, at a CAGR of 23.9% during the forecast period 2023 to 2030. Accomplishment of maximum return on investment (ROI) is one of the most wannabe goals for any...

The Japan Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) market is poised for significant growth, with its size projected to rise from USD 78.61 million in 2024 to USD 155.79 million by 2034, reflecting a compound annual growth rate (CAGR) of 7.10% over the forecast period. This market expansion is largely driven by increased awareness, advancements...

Antibody-drug conjugates (ADCs) represent a groundbreaking advancement in targeted cancer therapy, merging the specificity of monoclonal antibodies with the potency of cytotoxic drugs. By leveraging the unique properties of antibodies, ADCs selectively deliver highly concentrated doses of chemotherapy to cancer cells while minimizing damage to healthy tissues. This approach not only enhances...

  Overview of the Nuclear Medicine Market The nuclear medicine market is one of the most rapidly advancing segments in the healthcare industry, transforming the way diseases are diagnosed and treated. By utilizing small amounts of radioactive materials (radiotracers), nuclear medicine enables early detection of various conditions, including cancer, cardiovascular disorders, neurological...

The global peptide-based cancer therapeutics market is undergoing a period of rapid advancement, driven by the urgent need for effective, targeted cancer treatments and innovations in peptide drug design and delivery. According to recent industry analysis, the market was valued at USD 8.58 billion in 2019 and is projected to grow at a CAGR of 9.1%,...